Research and Development
Beyond Amyloids: New Targets for Alzheimer’s Drug Research in 2023
A Drug Industry Daily Special Report, Part 2
One Star and Several Flameouts Mark Alzheimer’s Drug Development in 2022
A Drug Industry Daily Special Report, Part 1